Teladoc Health Inc’s recently made public that its PRESIDENT, ENTERPRISE GROWTH Kornwasser Laizer unloaded Company’s shares for reported $0.13 million on May 02 ’24. In the deal valued at $12.69 per share,10,411 shares were sold. As a result of this transaction, Kornwasser Laizer now holds 86,070 shares worth roughly $1.1 million.
Then, Waters Michael Willem sold 5,793 shares, generating $73,502 in total proceeds. Upon selling the shares at $12.69, the CHIEF OPERATING OFFICER now owns 64,881 shares.
Before that, Raman-Tangella Vidya sold 3,691 shares. Teladoc Health Inc shares valued at $46,831 were divested by the CHIEF MEDICAL OFFICER at a price of $12.69 per share. As a result of the transaction, Raman-Tangella Vidya now holds 29,160 shares, worth roughly $0.37 million.
Cantor Fitzgerald initiated its Teladoc Health Inc [TDOC] rating to an Overweight in a research note published on February 29, 2024; the price target was $22. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”a Market perform”‘ rating. DA Davidson also remained covering TDOC and has decreased its forecast on January 17, 2024 with a “Neutral” recommendation from previously “Buy” rating. Barclays started covering the stock on January 03, 2024. It rated TDOC as “an Overweight”.
Price Performance Review of TDOC
On Friday, Teladoc Health Inc [NYSE:TDOC] saw its stock fall -1.62% to $12.78. Over the last five days, the stock has lost -1.77%. Teladoc Health Inc shares have fallen nearly -40.70% since the year began. Nevertheless, the stocks have fallen -50.31% over the past one year. While a 52-week high of $30.41 was reached on 01/02/24, a 52-week low of $12.53 was recorded on 05/01/24. SMA at 50 days reached $14.39, while 200 days put it at $18.94. A total of 6.2 million shares were traded, compared to the trading of 5.03 million shares in the previous session.
Levels Of Support And Resistance For TDOC Stock
The 24-hour chart illustrates a support level at 12.54, which if violated will result in even more drops to 12.30. On the upside, there is a resistance level at 13.25. A further resistance level may holdings at 13.71. The Relative Strength Index (RSI) on the 14-day chart is 36.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.55%. Stochastics %K at 19.39% indicates the stock is a buying.
The most recent change occurred on April 12, 2023 when Stephens began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $25 price target.
